| Characteristics | SRS (n = 5) | HSRT (n = 6) | FSRT (n = 2) | All patients (n = 13) |
|---|
| Tumor Volume (cm3) | 4.57 (0.52–8.76) | 13.33 (0.44–42.39) | 1.37 (0.32–2.41) | 8.12 (0.32–42.39 cc) |
| Number of Fractions | 1 | 3–5 | 25–28 | 1–28 |
| Prescription Dose (Gy) | 14.8 (13–18) | 27.3 (24–30) | 50.2 (50–50.4) | 13–50.4 |
| Dose Fraction (Gy) | 14.8 (13–18) | 6 (5–8) | 1.9 (1.8–2) | 1.8–18 |
| Prescription Isodose (%) | 76.7% (70–82%) | 79.3% (75–84%) | 86.5% (83–90%) | 79.38% (70–90%) |
| Maximum Dose (Gy) | 19.34 (17.33–24) | 34.42 (30–37.97) | 58.14 (55.56–60.72) | 32.27 (17.33–60.72) |
| Lesion Coverage | 96.3% (95.3–98.8%) | 95.03% (92.69–97.43%) | 96% (95.35–96.65%) | 95.66% (92.69–98.8%) |
| Conformality index | 1.26 (1.1–1.38) | 1.43 (1.22–1.77) | 1.8 (1.69–1.95) | 1.43 (1.1–1.95) |
| Total Beam | 191 (125–262) | 194 (91–268) | 161 (143–180) | 91–268 |
